Straumann Holding AG (SAUHY)
USD 12.99
(0.62%)
USD 12.99
(0.62%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.77 Billion CHF | 1.04% |
| 2022 | 1.75 Billion CHF | 13.94% |
| 2021 | 1.54 Billion CHF | 49.55% |
| 2020 | 1.02 Billion CHF | -14.22% |
| 2019 | 1.2 Billion CHF | 17.78% |
| 2018 | 1.01 Billion CHF | 21.27% |
| 2017 | 840.46 Million CHF | 16.97% |
| 2016 | 718.52 Million CHF | 16.85% |
| 2015 | 614.93 Million CHF | 10.08% |
| 2014 | 558.65 Million CHF | 4.24% |
| 2013 | 535.91 Million CHF | 0.83% |
| 2012 | 531.52 Million CHF | 0.56% |
| 2011 | 528.53 Million CHF | -9.96% |
| 2010 | 587.02 Million CHF | 0.03% |
| 2009 | 586.83 Million CHF | -7.07% |
| 2008 | 631.5 Million CHF | 8.46% |
| 2007 | 582.27 Million CHF | 7.64% |
| 2006 | 540.94 Million CHF | 18.25% |
| 2005 | 457.44 Million CHF | 22.03% |
| 2004 | 374.87 Million CHF | 36.42% |
| 2003 | 274.78 Million CHF | 24.6% |
| 2002 | 220.53 Million CHF | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 919.89 Million CHF | 6.71% |
| 2023 Q4 | 862.07 Million CHF | -5.37% |
| 2023 Q2 | 910.98 Million CHF | 12.36% |
| 2023 FY | 1.77 Billion CHF | 1.04% |
| 2022 Q4 | 810.76 Million CHF | -8.96% |
| 2022 Q2 | 890.51 Million CHF | 13.74% |
| 2022 FY | 1.75 Billion CHF | 13.94% |
| 2021 Q4 | 782.96 Million CHF | 4.91% |
| 2021 FY | 1.54 Billion CHF | 49.55% |
| 2021 Q2 | 746.29 Million CHF | 23.63% |
| 2020 Q2 | 422.64 Million CHF | -30.19% |
| 2020 FY | 1.02 Billion CHF | -14.22% |
| 2020 Q4 | 603.67 Million CHF | 42.83% |
| 2019 Q2 | 595.07 Million CHF | 17.53% |
| 2019 FY | 1.2 Billion CHF | 17.78% |
| 2019 Q4 | 605.39 Million CHF | 1.73% |
| 2018 FY | 1.01 Billion CHF | 21.27% |
| 2018 Q2 | 521.93 Million CHF | 24.14% |
| 2018 Q4 | 506.31 Million CHF | -2.99% |
| 2017 Q4 | 420.43 Million CHF | 0.09% |
| 2017 Q2 | 420.03 Million CHF | 17.54% |
| 2017 FY | 840.46 Million CHF | 16.97% |
| 2016 Q2 | 361.18 Million CHF | 15.38% |
| 2016 FY | 718.52 Million CHF | 16.85% |
| 2016 Q4 | 357.34 Million CHF | -1.06% |
| 2015 Q4 | 313.03 Million CHF | -0.59% |
| 2015 Q2 | 314.9 Million CHF | 14.41% |
| 2015 FY | 614.93 Million CHF | 10.08% |
| 2014 Q4 | 275.24 Million CHF | -2.88% |
| 2014 FY | 558.65 Million CHF | 4.24% |
| 2014 Q2 | 283.4 Million CHF | 9.12% |
| 2013 Q2 | 276.19 Million CHF | 0.0% |
| 2013 FY | 535.91 Million CHF | 0.83% |
| 2013 Q4 | 259.72 Million CHF | -5.96% |
| 2012 Q4 | - CHF | 0.0% |
| 2012 FY | 531.52 Million CHF | 0.56% |
| 2011 Q4 | - CHF | 0.0% |
| 2011 FY | 528.53 Million CHF | -9.96% |
| 2010 FY | 587.02 Million CHF | 0.03% |
| 2010 Q4 | - CHF | 0.0% |
| 2009 FY | 586.83 Million CHF | -7.07% |
| 2009 Q4 | - CHF | 0.0% |
| 2008 FY | 631.5 Million CHF | 8.46% |
| 2007 FY | 582.27 Million CHF | 7.64% |
| 2006 FY | 540.94 Million CHF | 18.25% |
| 2005 FY | 457.44 Million CHF | 22.03% |
| 2004 FY | 374.87 Million CHF | 36.42% |
| 2003 FY | 274.78 Million CHF | 24.6% |
| 2002 FY | 220.53 Million CHF | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | -104252.286% |
| Ansell Limited | 624.8 Million USD | -183.78% |
| Ansell Limited | 624.8 Million USD | -183.78% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 113.94 Million USD | -1456.105% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -1312740.695% |
| Psykey, Inc. | 415.97 Thousand USD | -426140.216% |
| ConvaTec Group Plc | 1.2 Billion USD | -47.374% |
| ConvaTec Group Plc | 1.17 Billion USD | -50.924% |
| Encision Inc. | 3.13 Million USD | -56439.493% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 794.01 Thousand USD | -223203.271% |
| LifePoint, Inc. | -71.35 Thousand USD | 2484834.718% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 1353578.626% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | -337625.143% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | -293822.319% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | -297182.792% |
| SmileDirectClub, Inc. | 275.84 Million USD | -542.768% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | -96.847% |
| SheerVision, Inc. | 2.17 Million USD | -81385.807% |
| United Health Products, Inc. | -4857.00 USD | 36505288.388% |
| Vasamed, Inc. | -69.38 Thousand USD | 2555379.011% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | -662321.403% |
| Yubo International Biotech Limited | 52.65 Thousand USD | -3367401.709% |